136 related articles for article (PubMed ID: 12182996)
1. How fast is repopulation of tumor cells during the treatment gap?
Tarnawski R; Fowler J; Skladowski K; Swierniak A; Suwiński R; Maciejewski B; Wygoda A
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):229-36. PubMed ID: 12182996
[TBL] [Abstract][Full Text] [Related]
2. Tumor cell repopulation during conventional and accelerated radiotherapy in the in vitro megacolony culture.
Tarnawski R; Widel M; Skladowski K
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):1074-81. PubMed ID: 12605987
[TBL] [Abstract][Full Text] [Related]
3. Time factor in postoperative radiotherapy: a multivariate locoregional control analysis in 868 patients.
Suwinski R; Sowa A; Rutkowski T; Wydmanski J; Tarnawski R; Maciejewski B
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):399-412. PubMed ID: 12738315
[TBL] [Abstract][Full Text] [Related]
4. Optimized Hypofractionation Can Markedly Improve Tumor Control and Decrease Late Effects for Head and Neck Cancer.
Shuryak I; Hall EJ; Brenner DJ
Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):272-278. PubMed ID: 30776451
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
6. Histopathologic validation of 3'-deoxy-3'-18F-fluorothymidine PET for detecting tumor repopulation during fractionated radiotherapy of human FaDu squamous cell carcinoma in nude mice.
Yue JB; Yang J; Liu J; Lee J; Cabrera AR; Sun XD; Bai GH; Li YH; Yu JM
Radiother Oncol; 2014 Jun; 111(3):475-81. PubMed ID: 24813091
[TBL] [Abstract][Full Text] [Related]
7. Radiation-free weekend rescued! Continuous accelerated irradiation of 7-days per week is equal to accelerated fractionation with concomitant boost of 7 fractions in 5-days per week: report on phase 3 clinical trial in head-and-neck cancer patients.
Skladowski K; Hutnik M; Wygoda A; Golen M; Pilecki B; Przeorek W; Rutkowski T; Lukaszczyk-Widel B; Heyda A; Suwinski R; Tarnawski R; Maciejewski B
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):741-6. PubMed ID: 22836063
[TBL] [Abstract][Full Text] [Related]
8. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
[TBL] [Abstract][Full Text] [Related]
9. [Preliminary results of accelerated hyperfractionated split course radiotherapy of advanced head and neck cancers].
Miszczyk L; Woźniak G; Maciejewski B; Tarnawski R
Otolaryngol Pol; 2003; 57(6):785-92. PubMed ID: 15049176
[TBL] [Abstract][Full Text] [Related]
10. The hazard of accelerated tumor clonogen repopulation during radiotherapy.
Withers HR; Taylor JM; Maciejewski B
Acta Oncol; 1988; 27(2):131-46. PubMed ID: 3390344
[TBL] [Abstract][Full Text] [Related]
11. Repopulation of moderately well-differentiated and keratinizing GL human squamous cell carcinomas growing in nude mice.
Hessel F; Krause M; Petersen C; Hörcsöki M; Klinger T; Zips D; Thames HD; Baumann M
Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):510-8. PubMed ID: 14751522
[TBL] [Abstract][Full Text] [Related]
12. Accelerated hyperfractionated irradiation with concomitant boost for stage II laryngeal cancer and locally advanced head and neck cancer.
Ishii K; Tashiro M; Hosono M; Fukuda H; Takada Y; Kondo S; Inoue Y; Iguchi H; Kusuki M; Yamane H
Acta Otolaryngol Suppl; 2004 Oct; (554):62-6. PubMed ID: 15513514
[TBL] [Abstract][Full Text] [Related]
13. Why to start the concomitant boost in accelerated radiotherapy for advanced laryngeal cancer in week 3.
Terhaard CH; Kal HB; Hordijk GJ
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):62-9. PubMed ID: 15850903
[TBL] [Abstract][Full Text] [Related]
14. Dose-time considerations of head and neck squamous cell carcinomas treated with irradiation.
Taylor JM; Withers HR; Mendenhall WM
Radiother Oncol; 1990 Feb; 17(2):95-102. PubMed ID: 2320748
[TBL] [Abstract][Full Text] [Related]
15. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: tumor dose-response and repopulation.
Maciejewski B; Withers HR; Taylor JM; Hliniak A
Int J Radiat Oncol Biol Phys; 1989 Mar; 16(3):831-43. PubMed ID: 2921175
[TBL] [Abstract][Full Text] [Related]
16. Improved results with accelerated hyperfractionated radiotherapy of advanced head and neck cancer.
Leborgne F; Zubizarreta E; Fowler J; Ortega B; Mezzera J; Deus JL; Leborgne JH
Int J Cancer; 2000 Apr; 90(2):80-91. PubMed ID: 10814958
[TBL] [Abstract][Full Text] [Related]
17. Cell repopulation and overall treatment time.
Trott KR
Int J Radiat Oncol Biol Phys; 1990 Oct; 19(4):1071-5. PubMed ID: 2211245
[TBL] [Abstract][Full Text] [Related]
18. Repopulation of FaDu human squamous cell carcinoma during fractionated radiotherapy correlates with reoxygenation.
Petersen C; Zips D; Krause M; Schöne K; Eicheler W; Hoinkis C; Thames HD; Baumann M
Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):483-93. PubMed ID: 11567825
[TBL] [Abstract][Full Text] [Related]
19. Impact of tumor repopulation on radiotherapy planning.
Wang JZ; Li XA
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):220-7. PubMed ID: 15629615
[TBL] [Abstract][Full Text] [Related]
20. Local control of carcinoma of the tonsil by radiation therapy: an analysis of patterns of fractionation in nine institutions.
Withers HR; Peters LJ; Taylor JM; Owen JB; Morrison WH; Schultheiss TE; Keane T; O'Sullivan B; van Dyk J; Gupta N
Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):549-62. PubMed ID: 7558943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
